NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ARMR Sciences Inc.

ARMR Sciences Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://armrsciences.com/

Last Round

Strategic

Jun 23, 2026

Company Overview

ARMR Sciences Inc. is a biotechnology company developing preventive immunotherapies and biodefense countermeasures to protect against synthetic drug threats such as fentanyl.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

fentanyl vaccinebiodefensemedical countermeasuressubstance use disorderopioid overdose preventionaddiction medicineclinical trialsbiotechnologyprophylactic vaccinebiosecuritydrug addiction vaccineoverdose antidoteB2Ggovernment contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ARMR Sciences Inc. Comps

Public and private peers based on sector, stage, and business model.

ARMR Sciences Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ARMR Sciences Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJun 23, 2026
Series A ExtensionAug 5, 2025

Key People

Founding team and executive leadership

Collin Gage

Co-founder & Chief Executive Officer

Founding Team

Jeff Neidhardt

Chief Financial Officer

Executive Team

ARMR Sciences Inc. Investors

Notable investors and investment history

ARMR Sciences Inc. investors
InvestorRounds
Zola GlobalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2025

    Launched a trial for its fentanyl vaccine.

ARMR Sciences Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ARMR Sciences Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ARMR Sciences Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2023
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.